Replies to post #60402 on Biotech Values

[microcapfun]

>>The latter, IMO.

The Avastin label in metastatic colorectal cancer, which includes use with all varieties of infusional-5FU chemotherapy, is a good precedent.<<

Thanks. I was thinking the former, i.e. that it would require a telaprevir/Albuferon trial to obtain FDA approval for that combination.

5FU has many years of experience behind it. I presume that there is very little difference between the different "varieties" of 5FU. It is not so clear that the *new* drug Albuferon would combine with the *new* drug telaprevir the same way that Pegasys combines with telaprevir ... as determined by a Phase 3 clinical trial.

micro